A population-based analysis of the impact of 1 vs. 2 doses of mitomycin on patterns of failure of anal cancer patients treated with concurrent chemoradiotherapy.
Joseph K, Al Habsi Z, Abraham A, Elangovan A, Ghosh S, Pham TM, Shreekumar D, Ramji Z, Paulson K, Tankel K, Usmani N, Severin D, Schiller D, Wong C, Mulder K, Karachiwala H, Doll C, King K, Nijjar T.
Joseph K, et al. Among authors: pham tm.
Radiother Oncol. 2024 Mar 11:110219. doi: 10.1016/j.radonc.2024.110219. Online ahead of print.
Radiother Oncol. 2024.
PMID: 38479443